Clinical Trial Update: UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy [Phase 3]

View source ↗

Summary

Phase 3 extension trial update for Total Therapy 3B in multiple myeloma; the study (UARK 2006-66) is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING